Ronald Marcus
Keine laufenden Positionen mehr
Karriereverlauf von Ronald Marcus
Ehemalige bekannte Positionen von Ronald Marcus
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KARA THER | Technik-/Wissenschafts-/F&E-Leiter | 26.01.2021 | 18.03.2024 |
Terran Biosciences
Terran Biosciences BiotechnologyHealth Technology Terran Biosciences is a biotech platform company that focuses on developing therapeutics and technologies for patients with neurological and psychiatric diseases. Terran Biosciences is based in New York, NY and has subsidiaries in the United States. The company has built a CNS-focused, tech-enabled drug development platform and is advancing a number of assets that include a late-stage therapeutic for schizophrenia, an FDA-cleared neuroimaging software platform, and a drug design engine that has generated first-in-class and psychedelic-based therapeutics. The company was founded by Samuel Clark, who has been the CEO since incorporation. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2019 | 01.10.2020 |
AVALO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.05.2015 | 17.11.2017 |
General Counsel | 29.05.2015 | 17.11.2017 | |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.1991 | 01.11.2013 |
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Spinifex Pharmaceuticals Pty Ltd. discovers and develops new drugs for the treatment and management of pain. The firm conducts medicinal chemistry and drug discovery activities, preclinical and early-phase clinical studies before seeking a partnership with pharmaceutical company to complete clinical development, file for regulatory approval, and carry out marketing activities. The company was founded in June 2005 and is headquartered in Preston, Australia. | Technik-/Wissenschafts-/F&E-Leiter | 03.06.2014 | - |
Ausbildung von Ronald Marcus
University of Virginia | Undergraduate Degree |
State University of New York at Buffalo | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Australien | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
AVALO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Spinifex Pharmaceuticals Pty Ltd. discovers and develops new drugs for the treatment and management of pain. The firm conducts medicinal chemistry and drug discovery activities, preclinical and early-phase clinical studies before seeking a partnership with pharmaceutical company to complete clinical development, file for regulatory approval, and carry out marketing activities. The company was founded in June 2005 and is headquartered in Preston, Australia. | Health Technology |
Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
Terran Biosciences
Terran Biosciences BiotechnologyHealth Technology Terran Biosciences is a biotech platform company that focuses on developing therapeutics and technologies for patients with neurological and psychiatric diseases. Terran Biosciences is based in New York, NY and has subsidiaries in the United States. The company has built a CNS-focused, tech-enabled drug development platform and is advancing a number of assets that include a late-stage therapeutic for schizophrenia, an FDA-cleared neuroimaging software platform, and a drug design engine that has generated first-in-class and psychedelic-based therapeutics. The company was founded by Samuel Clark, who has been the CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Ronald Marcus
- Erfahrung